
Reset all filters
01 1Bracco
Reset all filters
01 1IOMEPROL
Reset all filters
01 1Italy
Reset all filters
01 1Inactive
Reset all filters
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10299
Submission : 1993-06-15
Status : Inactive
Type : II
73
PharmaCompass offers a list of Iomeprol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iomeprol manufacturer or Iomeprol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iomeprol manufacturer or Iomeprol supplier.
PharmaCompass also assists you with knowing the Iomeprol API Price utilized in the formulation of products. Iomeprol API Price is not always fixed or binding as the Iomeprol Price is obtained through a variety of data sources. The Iomeprol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron;, including repackagers and relabelers. The FDA regulates 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; supplier is an individual or a company that provides 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; active pharmaceutical ingredient (API) or 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; finished formulations upon request. The 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; suppliers may include 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; API manufacturers, exporters, distributors and traders.
click here to find a list of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; active pharmaceutical ingredient (API) in detail. Different forms of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; DMFs exist exist since differing nations have different regulations, such as 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; DMF submitted to regulatory agencies in the US is known as a USDMF. 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; USDMF includes data on 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron;'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron; suppliers with USDMF on PharmaCompass.
We have 1 companies offering 1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-;Iomeron;Iomeron 350;N,N'-Bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide;Imeron;
Get in contact with the supplier of your choice: